Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Controlled, Observer-masked, Multi-center Clinical Trial to Demonstrate the Safety and Effectiveness of the Extended Depth of Focus AT LARA 829MP Posterior Chamber Intraocular Lens for Correction of Aphakia

NCT07092020 is registered in ClinicalTrials.gov with Carl Zeiss Meditec AG as lead sponsor.

NCT NCT07092020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07092020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Controlled, Observer-masked, Multi-center Clinical Trial to Demonstrate the Safety and Effectiveness of the Extended Depth of Focus AT LARA 829MP Posterior Chamber Intraocular Lens for Correction of Aphakia
Lead sponsor
Carl Zeiss Meditec AG
Phase
Not applicable
Overall status
Completed
Start date
October 1, 2025
Completion date
July 27, 2026
Enrollment
220 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

cataract senile